DBV Technologies (Nasdaq: DBVT) announced that it has reached its patient recruitment objective for PEPITES (PEanut EPIT® Efficacy and Safety) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE